Okyo Pharma Limited ADR (OKYO)
1.2700 x 1 1.4700 x 1
Post-market by (Cboe BZX)
1.3500 +0.0900 (+7.14%) 03/21/25 [NASDAQ]
1.2700 x 1 1.4700 x 1
Post-market 1.3900 +0.0400 (+2.96%) 19:54 ET
for Fri, Mar 21st, 2025
Results
download Want to compare other data? Select FieldsSymbol | OKYO | AZN | AMGN | GILD | VRTX |
Company | Okyo Pharma Limited ADR | Astrazeneca Plc ADR | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
Price Information | |||||
Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
Open | 1.2700 | 75.59 | 311.82 | 105.16 | 505.42 |
High | 1.3600 | 75.90 | 316.49 | 107.42 | 510.08 |
Low | 1.2700 | 74.68 | 311.16 | 104.92 | 501.07 |
Last | 1.3500 | 74.93 | 316.04 | 107.08 | 503.20 |
Change | +0.0900 | -1.59 | +1.00 | +1.21 | -6.98 |
% Change | +7.14% | -2.08% | +0.32% | +1.14% | -1.37% |
Volume | 33,000 | 5,173,000 | 9,995,000 | 26,497,500 | 2,280,500 |
20-Day Average Volume | 188,190 | 6,216,955 | 3,393,335 | 10,958,615 | 1,374,950 |
Previous Close | 1.2600 | 76.52 | 315.04 | 105.87 | 510.18 |
Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
Has Options | No | Yes | Yes | Yes | Yes |
Technicals | |||||
20-Day Moving Average | 1.3279 | 76.29 | 314.78 | 112.62 | 493.70 |
20-Day Raw Stochastic | 54.01% | 17.96% | 39.48% | 15.60% | 64.31% |
20-Day Relative Strength | 55.63% | 52.24% | 58.97% | 50.17% | 60.40% |
Weighted Alpha | +2.38 | +9.93 | +13.53 | +53.98 | +21.28 |
Today's Opinion | 80% Buy | 40% Buy | 56% Buy | 80% Buy | 72% Buy |
Previous Opinion | 64% Buy | 56% Buy | 56% Buy | 80% Buy | 56% Buy |
Last Month's Opinion | 8% Sell | 8% Buy | 24% Sell | 100% Buy | 24% Buy |
Performance | |||||
5-Days | |||||
%Chg | -10.52% since 03/14/25 | -3.44% since 03/14/25 | +0.74% since 03/14/25 | -3.91% since 03/14/25 | -0.31% since 03/14/25 |
Low | 1.2400 on 03/20/25 | 74.68 on 03/21/25 | 311.16 on 03/21/25 | 104.70 on 03/20/25 | 501.07 on 03/21/25 |
High | 1.5000 on 03/17/25 | 77.76 on 03/17/25 | 319.31 on 03/18/25 | 112.56 on 03/17/25 | 517.20 on 03/17/25 |
1-Month | |||||
%Chg | +21.08% since 02/21/25 | +0.96% since 02/21/25 | +4.30% since 02/21/25 | -2.61% since 02/21/25 | +3.92% since 02/21/25 |
Low | 1.0800 on 02/25/25 | 74.18 on 03/11/25 | 303.10 on 02/27/25 | 104.70 on 03/20/25 | 473.51 on 02/27/25 |
High | 1.5799 on 03/13/25 | 78.36 on 03/05/25 | 335.88 on 03/10/25 | 119.96 on 03/10/25 | 519.68 on 03/14/25 |
3-Month | |||||
%Chg | +27.36% since 12/20/24 | +14.66% since 12/20/24 | +19.99% since 12/20/24 | +15.67% since 12/20/24 | +26.66% since 12/20/24 |
Low | 0.9016 on 01/30/25 | 64.22 on 01/14/25 | 257.05 on 01/06/25 | 88.57 on 01/10/25 | 390.92 on 12/23/24 |
High | 1.5799 on 03/13/25 | 78.36 on 03/05/25 | 335.88 on 03/10/25 | 119.96 on 03/10/25 | 519.68 on 03/14/25 |
6-Month | |||||
%Chg | +33.66% since 09/20/24 | -4.40% since 09/20/24 | -6.33% since 09/20/24 | +27.57% since 09/20/24 | +8.23% since 09/20/24 |
Low | 0.9016 on 01/30/25 | 62.75 on 11/18/24 | 253.30 on 12/19/24 | 81.83 on 09/26/24 | 377.85 on 12/19/24 |
High | 1.5799 on 03/13/25 | 79.76 on 10/02/24 | 339.17 on 09/23/24 | 119.96 on 03/10/25 | 519.88 on 11/08/24 |
Key Statistics | |||||
Market Capitalization, $K | 45,679 | 232,373,984 | 169,778,272 | 133,351,648 | 129,216,736 |
Shares Outstanding, K | 33,836 | 3,101,214 | 537,205 | 1,245,346 | 256,790 |
Annual Sales | 0 | 54,073,000,000 | 33,424,000,000 | 28,754,000,000 | 11,020,100,000 |
Annual Net Income | -16,830,000 | 7,035,000,000 | 4,090,000,000 | 480,000,000 | -535,600,000 |
Last Quarter Sales | N/A | 14,891,000,000 | 9,086,000,000 | 7,569,000,000 | 2,912,000,000 |
Last Quarter Net Income | N/A | 1,499,000,000 | 627,000,000 | 1,783,000,000 | 913,000,000 |
60-Month Beta | -0.34 | 0.41 | 0.53 | 0.21 | 0.41 |
Per-Share Information | |||||
Most Recent Earnings | N/A | 1.05 on 02/06/25 | 5.31 on 02/04/25 | 1.90 on 02/11/25 | 3.98 on 02/10/25 |
Latest Earnings Date | 08/20/24 | 04/24/25 | 05/01/25 | 04/24/25 | 05/05/25 |
Most Recent Dividend | N/A | 1.030 on 02/21/25 | 2.380 on 02/14/25 | 0.790 on 03/14/25 | N/A |
Next Ex-Dividends Date | N/A | 02/21/25 | 05/16/25 | 03/14/25 | N/A |
Ratios | |||||
Price/Earnings ttm | 0.00 | 18.62 | 15.90 | 22.97 | 0.00 |